Compare Venture Global Inc. Class A common stock (VG) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Venture Global Inc. Class A common stock vs State Street SPDR S&P Biotech ETF — how do they compare? Venture Global Inc. Class A common stock trades at $13.19 (market cap $33.23B), while State Street SPDR S&P Biotech ETF trades at $154.08 (market cap $10.11B). The key difference: Venture Global Inc. Class A common stock is far larger — about 3.3× State Street SPDR S&P Biotech ETF's market cap, and Venture Global Inc. Class A common stock pays a 1.2% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Venture Global Inc. Class A common stock for 1 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| VG | XBI | |
|---|---|---|
Market Cap | $33.23B | $10.11B |
Volume | 12,625,066 | 12,903,266 |
Sector | Energy | Broad Market / Factor |
52-Week High | $17.53 | $169.55 |
52-Week Low | $5.92 | $104.99 |
Typical Hold Time | 1 Days | 38 Days |
Enterprise Value | $72.61B | — |
Dividend Yield | 1.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Venture Global Inc. Class A common stock
Venture Global develops, builds, and operates liquefied natural gas export facilities. Its projects connect U.S. natural gas supply with global LNG markets.
Read more on VG →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
